Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-02-08 Option Award | 2022-02-10 5:05 pm | N/A N/A | Sio Gene Therapies Inc. | SIOX | Nassif David W. Interim CEO, CFO | 546,500 | $0 | 546,500 (Direct) | View |
| 2021-12-08 Tax Withholding | 2021-12-09 6:31 pm | N/A N/A | Sio Gene Therapies Inc. | SIOX | Nassif David W. Chief Financial Officer | 6,294 | $1.42 | 80,310 (Direct) | View |
| 2021-12-08 Option Award | 2021-12-09 6:31 pm | N/A N/A | Sio Gene Therapies Inc. | SIOX | Nassif David W. Chief Financial Officer | 17,534 | $0 | 80,310 (Direct) | View |
| 2021-12-08 Disposition | 2021-12-09 6:31 pm | N/A N/A | Sio Gene Therapies Inc. | SIOX | Nassif David W. Chief Financial Officer | 17,534 | $0 | 80,310 (Direct) | View |
| 2021-04-15 Option Award | 2021-04-19 4:53 pm | N/A 2031-04-14 | Sio Gene Therapies Inc. | SIOX | Nassif David W. Chief Financial Officer | 239,000 | $0 | 239,000 (Direct) | View |
| 2021-03-22 Option Award | 2021-03-22 9:25 pm | N/A N/A | Sio Gene Therapies Inc. | SIOX | Nassif David W. Chief Financial Officer | 15,060 | $0 | 34,004 (Direct) | View |
| 2021-03-22 Disposition | 2021-03-22 9:25 pm | N/A N/A | Sio Gene Therapies Inc. | SIOX | Nassif David W. Chief Financial Officer | 15,060 | $0 | 34,004 (Direct) | View |
| 2020-06-11 Tax Withholding | 2020-06-15 7:40 pm | N/A N/A | Axovant Gene Therapies Ltd. | AXGT | Nassif David W. Principal Financial Officer | 5,266 | $3.25 | 34,004 (Direct) | View |
| 2020-06-11 Option Award | 2020-06-15 7:40 pm | N/A N/A | Axovant Gene Therapies Ltd. | AXGT | Nassif David W. Principal Financial Officer | 15,060 | $0 | 34,004 (Direct) | View |
| 2020-06-12 Disposition | 2020-06-15 7:40 pm | N/A N/A | Axovant Gene Therapies Ltd. | AXGT | Nassif David W. Principal Financial Officer | 15,060 | $0 | 34,004 (Direct) | View |
| 2020-04-15 Option Award | 2020-04-17 9:01 pm | N/A 2030-04-14 | Axovant Gene Therapies Ltd. | AXGT | Nassif David W. Principal Financial Officer | 131,500 | $0 | 131,500 (Direct) | View |
| 2019-09-21 Option Award | 2019-09-24 5:15 pm | N/A N/A | Axovant Gene Therapies Ltd. | AXGT | Nassif David W. Principal Financial Officer | 30,120 | $0 | 30,120 (Direct) | View |
| 2019-07-01 Option Award | 2019-07-02 6:15 pm | N/A 2029-06-30 | Axovant Gene Therapies Ltd. | AXGT | Nassif David W. Principal Financial Officer | 225,000 | $0 | 225,000 (Direct) | View |
Ownership | 2019-07-02 5:24 pm | N/A N/A | Axovant Gene Therapies Ltd. | AXGT | Nassif David W. Principal Financial Officer | 0 | $0 | 9,150 (Direct) | View |